Lingli Chen
Nanjing Agricultural University(CN)U.S. National Science Foundation(US)Sun Yat-sen University(CN)Longyan University(CN)Nantong University(CN)Fudan University(CN)Wenzhou Medical University(CN)First Affiliated Hospital of Wenzhou Medical University(CN)Zhongshan Hospital(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)Tea Research Institute(CN)Henan Institute of Science and Technology(CN)Henan Normal University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer Immunotherapy and Biomarkers, Cholangiocarcinoma and Gallbladder Cancer Studies, Nanoparticle-Based Drug Delivery, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors(2016)637 cited
- → Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer(2019)436 cited
- → A Microbiota-Derived Bacteriocin Targets the Host to Confer Diarrhea Resistance in Early-Weaned Piglets(2018)384 cited
- → Cancer Cell Membrane-Coated Gold Nanocages with Hyperthermia-Triggered Drug Release and Homotypic Target Inhibit Growth and Metastasis of Breast Cancer(2016)351 cited
- → Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin(2012)249 cited
- → Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations(2021)229 cited